Physician

Sunoj Abraham, MD

According to 2025 Medicare claims, Sunoj Abraham, MD (NPI: 1194790857) practices internal medicine in the Homosassa Springs, FL market, with the plurality of this provider's patient population coming from Citrus, FL. This provider's primary affiliated billing organization is MANOJ B SHUKLA MD PA (NPI: 1750318192; TIN: 592348526) and primary practice location at 34452-4720.

Abraham's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,048 traditional Medicare patients, billed 3,877 HCPCS/CPT codes, and received $362,228 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 1,827 prescription claims across 430 beneficiaries totaling $1,864,289 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 5,797 claims. Open Payments data shows 50 records totaling $1,619. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $623,900 to $362,228. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $446,788 to $1,864,289. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $331,923 and ending at $225,549.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,873	6,464	$623,900
2016	1,618	5,487	$476,120
2017	1,562	5,262	$441,178
2018	1,385	4,949	$426,134
2019	1,314	4,234	$391,147
2020	1,300	4,362	$420,957
2021	1,289	4,333	$425,183
2022	1,100	3,596	$354,157
2023	1,087	3,844	$387,097
2024	1,048	3,877	$362,228

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	452	2,282	$446,788
2016	432	2,256	$575,257
2017	370	1,653	$422,198
2018	326	1,390	$526,375
2019	346	1,448	$500,616
2020	378	1,660	$734,393
2021	381	1,680	$978,419
2022	343	1,522	$1,195,643
2023	410	1,634	$1,217,845
2024	430	1,827	$1,864,289

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	1,861	5,414	$388,532
2016	2,152	6,635	$317,535
2017	2,343	6,632	$249,653
2018	2,236	6,412	$230,046
2019	2,264	6,452	$245,928
2020	2,354	6,671	$298,871
2021	2,157	6,250	$313,873
2022	1,981	6,024	$297,472
2023	1,919	5,942	$330,096
2024	1,806	5,797	$263,161

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	306	702	$92
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	490	785	$90
94729	Test to examine how well the lungs exchange gases	200	201	$33
94727	Test to determine lung volumes using gas dilution or washout	200	201	$26
94060	Test to measure expiratory airflow and volume changes before and after medication administration	196	197	$22

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	296	20,250	$420,182
Ofev	Nintedanib Esylate	16	480	$215,726
Prolastin C	Alpha-1-Proteinase Inhibitor	13	322	$161,364
Wakix	Pitolisant Hcl	11	300	$150,593
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	106	5,639	$118,213

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	79	624	$43,983
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	35	$26,518
A7031	Face mask interface, replacement for full face mask, each	N	98	298	$21,755
A7030	Full face mask used with positive airway pressure device, each	N	100	256	$20,113
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	17	$17,170

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	50	$1,619	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sunoj Abraham, MD?

Tedicare shows public-source Medicare data for Sunoj Abraham, MD (NPI 1194790857), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sunoj Abraham, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sunoj Abraham, MD?

Sunoj Abraham, MD is linked to MANOJ B SHUKLA MD PA (billing NPI 1750318192) in the available physician profile data.

Does Sunoj Abraham, MD have Open Payments data?

Sunoj Abraham, MD has 50 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.